Viking Therapeutics, Inc. (VKTX)
8.01  0.02 (0.25%)  11-15 16:00
Open: 8.12
High: 8.16
Low: 7.92
Volume: 1,042,900
Ask: x
Bid: x
Market Cap: 579M
PE Ratio: -24.4
Exchange: NASDAQ Capital Market
Industry: Biotechnology
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 10.00
Resistance 1: 8.56
Pivot price: 7.37
Support 1: 7.16
Support 2: 6.30
52w High: 12.62
52w Low: 6.15
MSFT149.971.91 (1.29%)
TWTR29.250.36 (1.25%)
BAC32.930.23 (0.7%)
AMZN1739.49-15.11 (-0.86%)
FB195.11.95 (1.01%)
GM0 (0%)

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share
EPS -0.330
Book Value 3.920
PEG Ratio -0.45
Gross Profit 0.000
Profit Margin (%) 0.00
Operating Margin (%) 0.00
Return on Assets (ttm) -6.5
Return on Equity (ttm) -8.1
Headline news

Wed, 06 Nov 2019 14:00:00 +0000
Up 19.2%, Is Viking Therapeutics Stock Still a Buy?

Tue, 05 Nov 2019 20:24:09 +0000
Noteworthy Tuesday Option Activity: AMZN, VKTX, PLT

Mon, 09 Sep 2019 14:00:00 +0000
Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics

Tue, 13 Aug 2019 11:00:00 +0000
3 Top Small-Cap Stocks to Buy in August

Sun, 11 Aug 2019 13:15:00 +0000
Is Viking Therapeutics a Buy?

Fri, 05 Apr 2019 00:10:49 +0000
MACK Halts MM-310 Study, VKTX On Watch, NAII Hits New High

Share on Facebook Tweet this page Share on google plus

Foxchart international: United States Canada United Kingdom Australia New Zealand Singapore India

© All Rights Reserved. | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX